Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...

McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.

An arm of health care giant McKesson will pay $448,578 in back wages and interest as part of an agreement with the U.S.

In a report released today, Eric Coldwell from Robert W. Baird upgraded McKesson (MCK – Research Report) to a Buy, with a price target of $688.00. Eric Coldwell’s rating is based on McKesson’s ability ...

McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...

McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...

The health care giant agreed to pay $448,000 in back wages to resolve hiring discrimination allegations at a DFW facility.

To settle the case, McKesson will pay $448,578 in back wages and interest along with extending job offers to 32 eligible applicants. The company also agreed to revise its hiring procedures to ensure ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

“Federal contractors must not engage in discriminatory hiring practices, it is the responsibility of the employer to ensure ...